2018•Diabetes & Metabolism JournalOpen access

The Role of Advanced Glycation End Products in Diabetic Vascular Complications

Sang Youl Rhee, Young Seol Kim

Abstract

In cases of chronic hyperglycemia, advanced glycation end-products (AGEs) are actively produced and accumulated in the circulating blood and various tissues. AGEs also accelerate the expression of receptors for AGEs, and they play an important role in the development of diabetic vascular complications through various mechanisms. Active interventions for glucose and related risk factors may help improve the clinical course of patients by reducing AGEs. This review summarizes recent updates on AGEs that have a significant impact on diabetic vascular complications.

About this research paper

What this paper is about

Why it matters

OpenAlex reports 275 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Key concepts: Medicine, Glycation, Diabetes mellitus, Advanced glycation end-product, Intensive care medicine, Internal medicine, Bioinformatics, Endocrinology